Skip to Content

Femoston-conti 0.5 mg / 2.5 mg film-coated tablets

Licence status
Authorised: 18/02/2022
Active substances
Estradiol, Dydrogesterone
Dosage Form
Film-coated tablet
Licence number
PPA0465/464/002
Licence holder
PCO Manufacturing Ltd.

Licence information

ATC code
G03FA Progestogens and estrogens, fixed combinations, G03FA14 dydrogesterone and estrogen
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
18/02/2022